BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan

David Holley, Xconomy Texas —  San Antonio — [Updated 12/14/17, 11:54 p.m. See below.] ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

San Antonio's StemBioSys receives patent approval for stem cell technology
March 24, 2015

StemBioSys Inc. President and CEO Bob Hutchens said the San Antonio company has taken another important step toward commercialization of its technology. Courtesy of StemBioSys

By W. Scott Bailey, San Antonio Business Journal

StemBioSys Inc. has received approval for a patent that expands coverage of technology licensed from the University of Texas Health Science Center at San Antonio.

StemBioSys CEO Bob Hutchens said the patent approval represents an "important step" for the company as it moves toward commercializing its technology.

The "Maintenance and Propagation of Mesenchymal Stem Cells" patent - U.S. patent 8,961,955 - is an extension of the company's core high-performance micro environment technology, which enhances the isolation, expansion and delivery of various types of stem cells. The new patent covers application of the HPME technology for bone healing applications. This is an area that StemBioSys is actively pursuing as one of many potential therapeutic applications for the technology.

See Also
StemBioSys CEO to present at San Francisco biotech conference
2014 World Stem Cell Summit capped off big year for SA's biosciences

In January, StemBioSys participated in the international Biotech Showcase in San Francisco, where Hutchens presented the company's work in advanced stem cell technologies to investors and pharmaceutical executives.


Stay informed. Subscribe to BioMed SA news alerts.